Locost Opposition, Lenacapavir, (In201917006277)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
AIDS HEALTHCARE FOUNDATION [AHF] opposition, Lenacapavir, (202017010006)
Countries: India Date: 2025
-
AIDS HEALTHCARE FOUNDATION [AHF] opposition, Lenacapavir, (202017007904)
Countries: India Date: 2025
-
Vietnam Network of People Living with HIV (VNP+) opposition, Rilpivirine, (PCT/US2021/072453)
Countries: Viet Nam Date: 2025
-
Mylan Laboratories India opposition, Raltegravir, (4187/DELNP/2007)
Countries: India Date: 2018
-
Delhi Network of Positive People opposition, Lenacapavir, (201917006277)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017010006)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202017007904)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (7440/DELNP/2015)
Countries: India Date: 2021
-
Sankalp Rehabilitation Trust opposition, Lenacapavir, (202018020805)
Countries: India Date: 2021
-
LOW COST STANDARD THERAPEUTICS opposition, TAF/FTC, (201817001590)
Countries: India Date: 2023